BeOne Medicines Ltd.
ONC
58 insider filings · Latest: Oct 13, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 13, 2026 | Oct 15 9:08 PM | Xiaodong WangDirector, Other | Sale | 31,027 | $350.99 | $10.9M | 0(D) | View → |
| Sep 30, 2026 | Oct 2 8:53 PM | Chan Henry LeeSVP, General Counsel | Sale | 1,115 | $375.00 | $418.1K | 0(D) | View → |
| Sep 28, 2026 | Sep 30 9:11 PM | Xiaodong WangDirector, Other | Sale | 31,028 | $364.79 | $11.3M | 0(D) | View → |
| Sep 30, 2026 | Sep 30 8:20 PM | CHAN LEE | Proposed Sale | 1,115 | $365.27 | $407.3K | — | View → |
| Sep 8, 2026 | Sep 10 8:49 PM | Xiaodong WangDirector, Other | Sale | 38,287 | $349.10 | $13.4M | 0(D) | View → |
| Sep 8, 2026 | Sep 8 8:26 PM | XIAODONG WANG | Proposed Sale | 131,370 | $358.26 | $47.1M | — | View → |
| Sep 1, 2026 | Sep 3 9:17 PM | Titus B. BallPrincipal Accounting Officer | Sale | 132 | $355.86 | $47.0K | 0(D) | View → |
| Sep 1, 2026 | Sep 1 8:14 PM | TITUS BENJAMIN BALL | Proposed Sale | 132 | $355.86 | $47.0K | — | View → |
| Aug 25, 2026 | Aug 27 9:12 PM | Xiaobin WuPresident and COO | Sale | 280 | $380.00 | $106.4K | 0(D) | View → |
| Aug 25, 2026 | Aug 25 8:44 PM | XIAOBIN WU | Proposed Sale | 15,000 | $371.98 | $5.6M | — | View → |
| Aug 25, 2026 | Aug 25 8:01 PM | CORAZON D. SANDERS | Proposed Sale | 2,075 | $380.00 | $788.5K | — | View → |
| Aug 11, 2026 | Aug 14 12:54 AM | Chan Henry LeeSVP, General Counsel | Sale | 2,666 | $360.00 | $959.8K | 0(D) | View → |
| Aug 12, 2026 | Aug 12 9:53 PM | John OylerDirector, Chief Executive Officer | Sale | 54,892 | $358.15 | $19.7M | 0(D) | View → |
| Aug 11, 2026 | Aug 12 9:53 PM | John OylerDirector, Chief Executive Officer | Sale | 70,907 | $361.90 | $25.7M | 54,892(D) | View → |
| Aug 10, 2026 | Aug 12 9:53 PM | John OylerDirector, Chief Executive Officer | Sale | 115,011 | $357.87 | $41.2M | 125,799(D) | View → |
| Aug 11, 2026 | Aug 11 8:31 PM | CHAN LEE | Proposed Sale | 2,002 | $359.00 | $718.7K | — | View → |
| Aug 10, 2026 | Aug 10 8:36 PM | JOHN V OYLER | Proposed Sale | 240,810 | $348.27 | $83.9M | — | View → |
| Aug 3, 2026 | Aug 5 9:15 PM | Aaron RosenbergChief Financial Officer | Sale | 1,157 | $312.72 | $361.8K | 0(D) | View → |
| Jul 30, 2026 | Aug 3 9:18 PM | Chan Henry LeeSVP, General Counsel | Sale | 1,044 | $323.69 | $337.9K | 0(D) | View → |
| Aug 3, 2026 | Aug 3 8:50 PM | AARON ROSENBERG | Proposed Sale | 1,157 | $312.72 | $361.8K | — | View → |
Page 1 of 8
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 13, 2026 | Oct 15 9:08 PM | Xiaodong WangDirector, Other | Option Exercise | 403,351 | — | 403,364(D) | View → |
| Sep 28, 2026 | Sep 30 9:11 PM | Xiaodong WangDirector, Other | Option Exercise | 403,364 | — | 806,715(D) | View → |
| Sep 8, 2026 | Sep 10 8:49 PM | Xiaodong WangDirector, Other | Option Exercise | 403,351 | — | 1,210,079(D) | View → |
| Aug 11, 2026 | Aug 14 12:54 AM | Chan Henry LeeSVP, General Counsel | Option Exercise | 34,658 | — | 88,582(D) | View → |
| Jul 22, 2026 | Jul 24 8:51 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 21,697 | — | 98,930(D) | View → |
| Jul 20, 2026 | Jul 22 9:03 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 441,870 | — | 0(D) | View → |
| Jul 17, 2026 | Jul 17 9:36 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 840,164 | — | 441,870(D) | View → |
| Jul 16, 2026 | Jul 17 9:31 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 2,165,761 | — | 1,282,034(D) | View → |
| Jul 15, 2026 | Jul 17 9:31 PM | John OylerDirector, Chief Executive Officer | Option Exercise | 1,515,241 | — | 1,254,513(D) | View → |
| Jul 14, 2026 | Jul 15 1:26 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 1,736,800 | — | 462,866(D) | View → |
| Jul 13, 2026 | Jul 15 1:25 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 630,760 | — | 1,264,666(D) | View → |
| Jul 10, 2026 | Jul 15 1:25 AM | John OylerDirector, Chief Executive Officer | Option Exercise | 152,074 | — | 1,895,426(D) | View → |
| Jul 8, 2026 | Jul 10 8:44 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 8,632 | — | 105,300(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Lai WangPresident, Global Head of R&D | Grant/Award | 229,775 | — | 229,775(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Aaron RosenbergChief Financial Officer | Grant/Award | 137,865 | — | 137,865(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Xiaobin WuPresident and COO | Grant/Award | 229,775 | — | 229,775(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Chan Henry LeeSVP, General Counsel | Grant/Award | 87,308 | — | 87,308(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | John OylerDirector, Chief Executive Officer | Grant/Award | 344,669 | — | 344,669(D) | View → |
| Jun 11, 2026 | Jun 15 9:54 PM | Xiaodong WangDirector, Other | Grant/Award | 193,492 | — | 193,492(D) | View → |
| May 13, 2026 | May 15 8:39 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 4,316 | — | 107,848(D) | View → |
Page 1 of 2
Next →